<rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:dct="http://purl.org/dc/terms/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="https://doi.org/10.1002/cbic.202000051">
    <dct:isReferencedBy>CORDIS</dct:isReferencedBy>
    <dct:isReferencedBy>OpenAire</dct:isReferencedBy>
    <dct:isReferencedBy>Sygma</dct:isReferencedBy>
    <dct:isReferencedBy>Bielefeld Academic Search Engine (BASE)</dct:isReferencedBy>
    <dct:isReferencedBy>St Andrews Research Repository</dct:isReferencedBy>
    <dct:isReferencedBy>UnpayWall</dct:isReferencedBy>
    <dct:isReferencedBy>Crossref</dct:isReferencedBy>
    <dct:isReferencedBy>Edinburgh Research Explorer</dct:isReferencedBy>
    <dct:isReferencedBy>Microsoft Academic Graph</dct:isReferencedBy>
    <dct:isReferencedBy>Europe PubMed Central</dct:isReferencedBy>
    <dct:isReferencedBy>European Union Open Data Portal</dct:isReferencedBy>
    <dct:references>https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbic.202000051</dct:references>
    <dct:references>https://doi.org/10.1002/cbic.202000051</dct:references>
    <dcat:downloadURL rdf:resource="https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbic.202000051"/>
    <dct:isPartOf>ChemBioChem</dct:isPartOf>
    <dct:license>Open Access</dct:license>
    <dct:created>2020-01-31</dct:created>
    <dc:description>Abstract&lt;p&gt;Selectively fluorinated compounds are found frequently in pharmaceutical and agrochemical products where currently 25&#65506;&#65408;&#65427;30&#65506;&#65408;&#65417;% of optimised compounds emerge from development containing at least one fluorine atom. There are many methods for the site&#65506;&#65408;&#65424;specific introduction of fluorine, but all are chemical and they often use environmentally challenging reagents. Biochemical processes for C&#65506;&#65416;&#65426;F bond formation are attractive, but they are extremely rare. In this work, the fluorinase enzyme, originally identified from the actinomycete bacterium Streptomyces cattleya, is engineered into Escherichia coli in such a manner that the organism is able to produce 5&#65506;&#65408;&#65458;&#65506;&#65408;&#65424;fluorodeoxyadenosine (5&#65506;&#65408;&#65458;&#65506;&#65408;&#65424;FDA) from S&#65506;&#65408;&#65424;adenosyl&#65506;&#65408;&#65424;l&#65506;&#65408;&#65424;methionine (SAM) and fluoride in live E.&#65506;&#65408;&#65413;coli cells. Success required the introduction of a SAM transporter and deletion of the endogenous fluoride efflux capacity in order to generate an E.&#65506;&#65408;&#65413;coli host that has the potential for future engineering of more elaborate fluorometabolites.&lt;/p&gt;</dc:description>
    <dc:subject>SAM transporters</dc:subject>
    <dc:subject>0301 basic medicine</dc:subject>
    <dc:subject>570</dc:subject>
    <dc:subject>S-Adenosylmethionine</dc:subject>
    <dc:subject>0303 health sciences</dc:subject>
    <dc:subject>Deoxyadenosines</dc:subject>
    <dc:subject>Halogenation</dc:subject>
    <dc:subject>DAS</dc:subject>
    <dc:subject>Fluorine</dc:subject>
    <dc:subject>Halogenations</dc:subject>
    <dc:subject>540</dc:subject>
    <dc:subject>QD Chemistry</dc:subject>
    <dc:subject>Streptomyces</dc:subject>
    <dc:subject>3. Good health</dc:subject>
    <dc:subject>03 medical and health sciences</dc:subject>
    <dc:subject>Bacterial Proteins</dc:subject>
    <dc:subject>Isomerism</dc:subject>
    <dc:subject>Escherichia coli</dc:subject>
    <dc:subject>QD</dc:subject>
    <dc:subject>Fluoride channels</dc:subject>
    <dc:subject>Genetic Engineering</dc:subject>
    <dc:subject>Oxidoreductases</dc:subject>
    <dc:subject>Fluorinases</dc:subject>
    <dc:creator rdf:resource="https://orcid.org/0000-0003-0018-5466"/>
    <dc:creator rdf:resource="https://orcid.org/0000-0003-1568-0750"/>
    <dc:creator rdf:resource="https://orcid.org/0000-0002-0510-5552"/>
    <dc:creator>Konstantinos Markakis, Phillip T. Lowe, Liam Davison&#8208;Gates, David O'Hagan, Susan J. Rosser, Alistair Elfick, </dc:creator>
    <dc:date>2020-03-03</dc:date>
    <dc:type>journalpaper</dc:type>
    <dct:abstract>Abstract&lt;p&gt;Selectively fluorinated compounds are found frequently in pharmaceutical and agrochemical products where currently 25&#65506;&#65408;&#65427;30&#65506;&#65408;&#65417;% of optimised compounds emerge from development containing at least one fluorine atom. There are many methods for the site&#65506;&#65408;&#65424;specific introduction of fluorine, but all are chemical and they often use environmentally challenging reagents. Biochemical processes for C&#65506;&#65416;&#65426;F bond formation are attractive, but they are extremely rare. In this work, the fluorinase enzyme, originally identified from the actinomycete bacterium Streptomyces cattleya, is engineered into Escherichia coli in such a manner that the organism is able to produce 5&#65506;&#65408;&#65458;&#65506;&#65408;&#65424;fluorodeoxyadenosine (5&#65506;&#65408;&#65458;&#65506;&#65408;&#65424;FDA) from S&#65506;&#65408;&#65424;adenosyl&#65506;&#65408;&#65424;l&#65506;&#65408;&#65424;methionine (SAM) and fluoride in live E.&#65506;&#65408;&#65413;coli cells. Success required the introduction of a SAM transporter and deletion of the endogenous fluoride efflux capacity in order to generate an E.&#65506;&#65408;&#65413;coli host that has the potential for future engineering of more elaborate fluorometabolites.&lt;/p&gt;</dct:abstract>
    <dc:title>An Engineered E.&#8197;coli Strain for Direct in Vivo Fluorination</dc:title>
    <dc:identifier>10.1002/cbic.202000051</dc:identifier>
  </rdf:Description>
</rdf:RDF>